Editing
CUA: Antibiotic Prophylaxis (2015)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
'''See [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336023/ Original Guideline]''' * '''Risk factors for post-procedure infection:''' *# '''Extremes of age''' *# '''Immunosuppressed''' *# '''Nutritional status''' *# '''Obesity''' *# '''Diabetes mellitus''' {| class="wikitable" |'''Procedure''' |'''Prophylaxis recommendation''' |'''Details''' |- |'''Diagnosis procedures (cystoscopy, urodynamics, retrograde pyelography, etc.)''' |'''High-risk''' | * Pre-procedural antibiotics show a strong trend towards reducing the risk of UTI, but not fever, after endoscopic urologic procedures |- |'''TRUS biopsy''' |'''All''' | * '''High risk of adverse infection-related events in patients undergoing transrectal prostate biopsy.''' Β * '''Insufficient evidence for efficacy of pre-procedural enemas to recommend their routine use.''' * In patients at increased risk of harboring resistant organisms (previous history of urosepsis, or multiple treatments with antibiotics, perirectal culture swabs prior to transrectal prostate biopsy should be considered. |- |'''TURP''' |'''All''' | * Pre-procedural antibiotics reduce the risk of febrile UTI after TURP |- |'''TURBT''' |'''High-risk''' | |- |'''ESWL''' |'''High-risk''' | * Pre-procedural antibiotics do not significantly reduce the risk of UTI and fever in patients undergoing ESWL but should be considered in patients at high risk of infectious complications. * '''Patients with large stone burden, associated pyuria, history of pyelonephritis, and adjunctive operative procedure including stent, nephrostomy insertion, PCNL or ureteroscopy are at a higher risk of developing pyelonephritis post-ESWL'''. |- |'''Stone manipulation procedures (URS, PCNL)''' |'''All''' | * Antibiotics reduce the risk of UTI following non-ESWL stone manipulation procedures, and there is a trend towards a reduction in the incidence of fever. |} * The choice of specific agent for prophylaxis should be based, in part, on the local epidemiology of drug resistance in potential uropathogens * '''The American Heart Association no longer recommends urologic prophylaxis to prevent endocarditis in at-risk patients'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information